KANSAS CITY, Kan., Nov. 3, 2015 /PRNewswire/ -- A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment. The trial turns the patient's own body into a cancer fighting machine. T-cells taken from the patient are modified and multiplied and then given back to the patient through an infusion. The patients in the current trial suffer diffuse large B cell non-Hodgkin's lymphoma -- the most common type of lymphoma. CAR T-cell therapy has proven successful in fighting blood cancers and doctors believe it could be adapted to target other cancers like breast and colon.
"Think of 'Pac-Man'," Joseph McGuirk, DO, and medical director of the Blood and Marrow Transplant Program at The University of Kansas Cancer Center said. "The patient's re-engineered cells are trained to chase down the cancer and destroy it."
Patients enrolled in the trial include a 26-year-old mother of two from Atchison, Kan. and a businessman from Australia who relocated his family temporarily for a chance at this cancer trial. NCI Designation makes this trial possible.
To view a video of Dr. McGuirk and the patient from Atchison, Kan.: https://youtu.be/4xvu9AUw92c
To view a video of Carl Adams of Perth, Australia, his wife Stacey and daughters Jade, age 11 and Amber, age 6: https://www.youtube.com/watch?v=DaLX7PwcX2Q
About The University of Kansas Cancer Center
The University of Kansas Cancer Center is a National Cancer Institute (NCI)-designated Cancer Center transforming cancer research and clinical care by linking an innovative approach to drug discovery, delivery and development to a nationally-accredited patient care program. KU Cancer Center partners with cancer research and healthcare professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, Kan., the University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita and Salina, and the members of the Midwest Cancer Alliance. KU Cancer Center's NCI Consortium partners include The Stowers Institute for Medical Research and Children's Mercy in Kansas City, Mo. For more information on The University of Kansas Cancer Center's research and outreach programs and award-winning patient care offered at the Richard and Annette Bloch Cancer Care Pavilion and The University of Kansas Hospital, please visit http://kucancercenter.org or call 1-800-332-6048.
SOURCE The University of Kansas Cancer Center
You just read:
The University of Kansas Cancer Center is the First in the World to Enroll Patients in a New Cancer Trial Considered the Future of Cancer Treatment
Nov 03, 2015, 07:34 EST